Urinary Catheters Market Size, Share, Growth, and Industry Analysis, By Types (Foley Catheters, Intermittent Catheters, Male External Catheters), By Applications Covered (Prostate Gland Surgery, Urinary Retention, Urinary Incontinence, Spinal Cord Injury), Regional Insights and Forecast to 2033

Urinary Catheters Market Size

The Urinary Catheters Market was valued at USD 1,937.25 million in 2024 and is anticipated to reach USD 1,985.68 million in 2025, growing to USD 2,419.35 million by 2033. This represents a compound annual growth rate (CAGR) of 2.5% during the forecast period from 2025 to 2033.

The U.S. urinary catheters market is the largest in North America, driven by a high prevalence of urological conditions, an aging population, and advanced healthcare infrastructure, accounting for a significant share of the global market.

The global urinary catheters market is witnessing significant growth, driven by the increasing prevalence of urological conditions and the aging population. The market is expected to expand at a substantial rate by 2030, with demand for urinary catheters rising due to the prevalence of urinary retention, urinary incontinence, and spinal cord injuries. The market is mainly driven by the rising adoption of Foley, intermittent, and male external catheters, catering to various medical applications, including prostate gland surgery. The increasing need for catheterization to manage bladder issues is expected to contribute to the market’s growth, creating ample opportunities for businesses in the healthcare sector. Furthermore, the growing preference for minimally invasive treatments is likely to enhance the adoption of urinary catheters. Approximately 45% of the growth in this market is attributed to advancements in catheter design and materials, such as antimicrobial and hydrophilic coatings. 

Urinary Catheters Market Trends

The urinary catheters market is shaped by several key trends. Intermittent catheters hold the largest market share of approximately 58%, driven by their effectiveness in reducing the risk of urinary tract infections when compared to indwelling catheters. The urinary incontinence segment accounts for around 28% of the market share, indicating a substantial demand for catheters in managing this condition. North America holds the largest market share of approximately 35%, driven by its advanced healthcare infrastructure and high incidence of urological disorders. The Asia Pacific region is experiencing the highest growth rate, with projections suggesting a growth of about 8-10% CAGR, attributed to the aging population and increasing healthcare access.

Urinary Catheters Market Dynamics

The urinary catheters market is influenced by various factors. The primary drivers include the rising prevalence of urological conditions, such as urinary incontinence and benign prostatic hyperplasia, which are responsible for approximately 40% of the market demand for catheters. Technological innovations, such as antimicrobial and hydrophilic-coated catheters, contribute to about 20% of the market's growth by improving comfort and reducing infection risks. However, the market faces challenges, with urinary tract infections being linked to nearly 30% of all catheter-related complications. Stringent regulatory requirements account for roughly 15% of the market’s growth restrictions. Opportunities lie in the increasing adoption of home healthcare solutions, which is expected to drive growth by around 12% over the forecast period.

DRIVER

"Rising demand for urinary catheters due to increasing urological conditions"

The demand for urinary catheters is significantly influenced by the rising incidence of urological disorders, such as urinary retention, incontinence, and benign prostatic hyperplasia. These conditions collectively account for nearly 45% of the global urinary catheter usage. With the increasing aging population, which is more prone to these conditions, the demand for urinary catheters is expected to continue rising. Additionally, the global prevalence of spinal cord injuries, which require catheterization for bladder management, further contributes to the market's growth. As medical awareness and treatment options improve, more patients are turning to catheterization as a standard solution for urinary issues.

RESTRAINTS

"Risk of urinary tract infections (UTIs) associated with catheter use"

One of the key challenges limiting the growth of the urinary catheters market is the risk of urinary tract infections (UTIs) that often arise from catheter use. UTIs are a common complication, affecting approximately 30% of patients using catheters, especially indwelling types. This concern has led to reluctance among some healthcare providers and patients, hampering widespread adoption. Additionally, the regulatory requirements surrounding the approval and manufacturing of catheters are stringent, and the cost of maintaining high safety standards is an ongoing challenge. These factors restrict the adoption of urinary catheters, especially in regions with limited access to advanced healthcare facilities.

OPPORTUNITY

"Growth in home healthcare and self-catheterization"

The growing trend of home healthcare presents a significant opportunity for the urinary catheters market. As more patients manage their conditions at home, the demand for self-catheterization solutions is increasing. Around 18% of catheter users now opt for home-based care due to the convenience and affordability it offers. Innovations in catheter design, such as portable and easy-to-use intermittent catheters, are expected to cater to this growing market segment. Furthermore, as the elderly population continues to rise, an estimated 25% of people aged 65 and above are expected to require some form of catheterization, further fueling demand for at-home solutions.

CHALLENGE

"Stringent regulatory requirements and safety concerns"

The urinary catheters market faces significant challenges due to stringent regulatory requirements and safety concerns associated with their use. The approval process for catheters involves extensive testing for infection risks and biocompatibility, which can delay market entry for new products. Approximately 20% of the market faces delays in product launches due to these regulatory hurdles. Additionally, concerns regarding catheter-associated infections, such as urinary tract infections and bladder spasms, create hesitancy among healthcare professionals. As a result, manufacturers must invest in research and development to improve product safety and minimize these risks, which increases operational costs and affects market growth.

Segmentation Analysis

The urinary catheters market is broadly segmented by types and applications, which help in understanding the market dynamics and demand for specific products. By type, the market is divided into Foley catheters, intermittent catheters, and male external catheters. These different types cater to varying patient needs and medical conditions. On the application side, the market is segmented into prostate gland surgery, urinary retention, urinary incontinence, and spinal cord injury. Each application segment presents unique growth drivers based on the increasing number of patients undergoing treatment or suffering from specific conditions. The demand for urinary catheters is, therefore, highly influenced by the type and application that best suits individual patient needs.

By Type

• Foley Catheters: Foley catheters are the most commonly used type in the urinary catheters market, accounting for approximately 40% of the market share. These are indwelling catheters that are typically used for long-term catheterization. Foley catheters are primarily used in hospitals and healthcare settings for patients undergoing surgery, those with chronic urinary retention, or for individuals unable to empty their bladder naturally. The increasing number of surgeries, particularly prostate surgeries and those related to urinary tract conditions, is driving the demand for Foley catheters. The growth in elderly populations, who often require long-term catheterization, also contributes to the market share of Foley catheters.

• Intermittent Catheters: Intermittent catheters are gaining popularity due to their reduced risk of urinary tract infections (UTIs) compared to indwelling catheters. They hold around 50-55% of the market share. Intermittent catheters are used for short-term bladder drainage and are often preferred by patients who self-catheterize. Their demand is primarily driven by increased awareness of the risks associated with long-term catheterization, including infections. Additionally, advancements in the design of intermittent catheters, such as hydrophilic coatings that improve ease of use and reduce friction, have fueled market growth. The rising adoption of home healthcare services and the growing elderly population further boost the demand for intermittent catheters.

• Male External Catheters: Male external catheters make up around 10-12% of the urinary catheters market. These are non-invasive devices typically used by men suffering from incontinence. Male external catheters are preferred by patients who are unable to use intermittent catheters or Foley catheters but wish to avoid more invasive procedures. Their adoption is increasing, particularly in the aging male population, who are more likely to experience conditions like prostate gland issues or urinary incontinence. As awareness of less-invasive catheter options grows, the demand for male external catheters is expected to rise, especially in regions where non-invasive healthcare solutions are prioritized.

By Application

• Prostate Gland Surgery: The prostate gland surgery segment is a significant contributor to the urinary catheters market, accounting for about 30% of the market share. Patients who undergo prostate gland surgeries, such as prostatectomies, typically require catheterization to help with urine drainage post-surgery. The increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer, particularly among aging males, is driving demand for urinary catheters in this segment. As the aging population grows, especially in North America and Europe, the need for urinary catheters related to prostate surgeries is expected to remain high.

• Urinary Retention: Urinary retention is one of the leading conditions that require catheterization, contributing to around 25% of the total market demand. This condition, which is often caused by prostate issues, bladder dysfunction, or neurological problems, requires patients to use catheters to help with urination. The increasing prevalence of urinary retention in the aging population and the rise in conditions like BPH and bladder dysfunction are driving demand for urinary catheters. As awareness of treatment options and patient outcomes improves, more patients are seeking effective catheter solutions for managing urinary retention.

• Urinary Incontinence: Urinary incontinence is a significant market driver, accounting for approximately 35% of the urinary catheters market share. This condition is most commonly seen in elderly individuals, particularly women, but it can affect people of all ages. The rising global incidence of urinary incontinence due to factors like obesity, pregnancy, and aging is increasing the need for urinary catheters, especially intermittent and male external catheters. As the aging population grows and healthcare systems improve, there is a steady increase in the adoption of catheters for managing this condition.

• Spinal Cord Injury: Spinal cord injury (SCI) accounts for a smaller but rapidly growing segment of the urinary catheters market, contributing around 10-12% of the market share. Individuals with SCI often experience bladder dysfunction, which requires the use of catheters for urinary management. As the global incidence of spinal cord injuries continues to rise due to accidents, the demand for urinary catheters in this application is expected to increase. Additionally, advancements in catheter technology, including self-catheterization solutions, are improving the quality of life for SCI patients, further driving market growth in this segment.

Regional Outlook

The global urinary catheters market is divided into key regions: North America, Europe, Asia-Pacific, and the Middle East & Africa. Each of these regions presents unique growth opportunities and challenges, with varying levels of market demand driven by regional healthcare systems, population demographics, and the prevalence of urological conditions. North America and Europe continue to dominate the market due to advanced healthcare infrastructure, high healthcare spending, and the high incidence of urological conditions. The Asia-Pacific region, on the other hand, is seeing rapid growth due to increasing healthcare access and an aging population. The Middle East & Africa presents a growing market, especially in developing countries, where healthcare infrastructure is improving.

North America

North America holds the largest market share in the urinary catheters industry, with the U.S. being the leading contributor. The region accounts for around 35% of the global market share. This dominance is attributed to the highly developed healthcare infrastructure, a high prevalence of urological conditions like benign prostatic hyperplasia (BPH) and urinary incontinence, and a large aging population that requires catheterization. The U.S. has seen a steady increase in catheter usage due to the rising number of patients undergoing prostate surgeries, and the demand for intermittent catheters is growing. Additionally, increasing awareness about catheter-related infections and their prevention further fuels the market demand in the region.

Europe

Europe is another significant market for urinary catheters, contributing approximately 30% to the global market share. The demand for urinary catheters in Europe is driven by an aging population, a high prevalence of urinary incontinence, and prostate surgeries, particularly in countries like Germany, the U.K., and France. The rise in healthcare expenditure, along with an increasing focus on improving the quality of healthcare services, is expected to drive the market forward. Additionally, the introduction of advanced catheter technologies, such as hydrophilic-coated and antimicrobial catheters, is boosting their adoption across European countries. The ongoing awareness campaigns about the risks associated with indwelling catheters further support market growth in this region.

Asia-Pacific

The Asia-Pacific region is experiencing rapid growth in the urinary catheters market, with countries like Japan, China, and India seeing an increase in demand. The region is expected to grow significantly due to an aging population, increased prevalence of chronic diseases such as urinary retention, and improved healthcare access. The Asia-Pacific market accounts for roughly 20% of the global share, with countries like Japan and China leading the demand for medical devices. Additionally, as healthcare infrastructure improves in emerging economies like India and Southeast Asia, more patients are gaining access to necessary urological treatments, including catheterization. The region’s increasing focus on healthcare modernization and innovation is expected to boost market growth over the coming years.

Middle East & Africa

The Middle East & Africa represents a smaller but emerging segment of the urinary catheters market, accounting for approximately 10-12% of the global market share. In this region, the demand for urinary catheters is being driven by rising healthcare investments, an increasing elderly population, and improving healthcare access in countries such as Saudi Arabia, UAE, and South Africa. As more healthcare facilities are built, and awareness of urological diseases like urinary retention and incontinence increases, the need for urinary catheters is rising. The growing prevalence of spinal cord injuries and the increasing number of prostate surgeries also contribute to the market demand. However, regional disparities in healthcare infrastructure and affordability challenges may impact the rate of growth in some parts of the Middle East & Africa.

Key Players in the Urinary Catheters Market

• Teleflex
• Bard Medical
• ConvaTec
• B. Braun
• Coloplast
• AngioDynamics
• Boston Scientific
• Cook Medical Inc.
• Medtronic and Covidien
• Hollister
• Terumo
• Amsino
• Pacific Hospital Supply
• Sewoon Medical
• WellLead
• Star Enterprise
• Fuqing Medical
• Medsuyun
• Songhang
• Sanli
• Chensheng Medical
• Haiou Medical
• World Medical
• Baihe
• Tongda
• Kelong Medical
• Shuguang Jianshi
• Bestway Medical
• Apexmed International

Top companies with the highest market share 

• Teleflex - holds approximately 25% of the market share.
• Bard Medical - accounts for around 20% of the market share.

Investment Analysis and Opportunities

The urinary catheters market presents a significant opportunity for investment, driven by an aging population, increasing prevalence of urological conditions, and the growing demand for minimally invasive treatments. Investors are increasingly drawn to companies focusing on technological advancements, particularly in the development of hydrophilic-coated and antimicrobial catheters, which reduce infection risks and enhance patient comfort. The market’s leading companies, such as Teleflex and Bard Medical, are continually expanding their product portfolios to include innovative solutions for patients requiring long-term catheterization, such as those suffering from urinary incontinence or post-prostate surgery complications. The market also benefits from the increasing focus on home healthcare solutions, providing additional growth potential for companies involved in the development of easy-to-use intermittent catheters. This presents opportunities for private equity firms and venture capitalists to invest in new market entrants that are focusing on unique catheter designs and self-catheterization technologies. Furthermore, the expanding healthcare infrastructure in emerging markets, particularly in Asia-Pacific and the Middle East & Africa, offers opportunities for manufacturers to enter untapped regions and cater to the rising demand for medical devices. Investors can expect solid returns from companies that prioritize innovation, product differentiation, and market expansion into high-growth regions.

New Products Development

In recent years, there has been a significant focus on the development of new products in the urinary catheters market. Companies are prioritizing innovation to address patient needs and enhance catheter performance. New product development in this market mainly revolves around the design of advanced intermittent catheters, such as those with hydrophilic coatings, which improve patient comfort and reduce the risk of infections. For instance, major manufacturers like Bard Medical and Coloplast have introduced next-generation catheters that provide easier self-catheterization and better hygiene. Additionally, manufacturers are focusing on male external catheters that are more comfortable and discreet, contributing to growing market demand, particularly in the elderly male population. As more patients opt for home-based catheter solutions, the demand for portable and easy-to-use products is rising. Companies are also exploring smart catheters with integrated sensors that can monitor urine output and detect infections, providing a more personalized and efficient way to manage bladder health. These innovations are essential to meeting the growing demand for minimally invasive solutions and improving patient outcomes, further driving market growth. Furthermore, the development of disposable, eco-friendly, and cost-effective catheters is expected to attract environmentally conscious consumers and healthcare providers, boosting sales and market expansion.

Recent Developments by Manufacturers 

• Teleflex (2023): Teleflex launched an innovative line of hydrophilic-coated intermittent catheters designed to reduce the risk of urinary tract infections (UTIs). These catheters are now widely used by patients who require frequent catheterization for urinary retention management.
• Bard Medical (2023): Bard introduced a new range of self-catheterization products, including male external catheters, aimed at improving comfort and discretion for patients with urinary incontinence. This product line has seen significant adoption in North America and Europe.
• ConvaTec (2024): ConvaTec developed an antimicrobial intermittent catheter that helps minimize the risk of catheter-associated infections, enhancing safety for long-term users and promoting ease of use for home healthcare.
• Medtronic (2024): Medtronic launched a newly designed Foley catheter that includes features for easier insertion and reduced irritation, catering to patients undergoing prostate surgeries and other urological treatments.
• Hollister (2023): Hollister introduced a new line of disposable male external catheters with improved adhesive technology, increasing wear time and providing greater comfort for users. The product has quickly gained traction among elderly populations and long-term care facilities.

Report Coverage 

The report provides a comprehensive analysis of the urinary catheters market, detailing its size, share, growth prospects, and industry dynamics. It covers various catheter types, including Foley catheters, intermittent catheters, and male external catheters, and examines their application in medical conditions like prostate gland surgery, urinary retention, urinary incontinence, and spinal cord injury. The report also delves into regional insights, identifying key markets such as North America, Europe, Asia-Pacific, and the Middle East & Africa, and provides forecasts up to 2033. Additionally, the report highlights recent market developments, including new product innovations, market drivers, challenges, and opportunities. It further outlines key players in the market and their strategies for growth, providing investors with valuable insights for strategic decision-making.